治疗儿童和青少年注意力缺陷/ 过度活动障碍的甲基
Ole J Storebø1, Erik Simonsen2, Christian Gluud3
1Psychiatric Research Unit, Child and Adolescent Psychiatric Department, Region Zealand Psychiatry, Region Zealand, Denmark.
甲基酸可能改善注意力缺陷/多动症 (ADHD) 症状和行为,但证据质量较低. 这种药物与不严重的副作用有关,对严重事件的数据有限.
科学领域:
- 儿童神经病学
- 儿童和青少年精神病学
- 药理学
背景情况:
- 注意缺陷/多动症 (ADHD) 是儿童和青少年常见的神经发育障碍.
- 甲基胺是一种广泛使用的ADHD治疗兴奋剂药物.
- 了解甲基酸的益处和危害对于临床决策至关重要.
研究的目的:
- 评估甲基酸盐治疗与儿童多动症的结果之间的关联.
- 评估甲基酸在患有ADHD的儿童和青少年的潜在益处和危害.
主要方法:
- 随机对照试验的系统审查和元分析.
- 包括评估甲基胺在儿童ADHD群体中的有效性和安全性的研究.
- 评估ADHD症状,一般行为,生活质量和不良事件.
主要成果:
- 甲基酸与ADHD症状,一般行为和生活质量的改善有关.
- 支持这些改进的证据质量非常低,使得规模不确定.
- 在使用甲基酸盐时,观察到非严重不良事件的风险增加.
- 没有足够的数据来评估与严重不良事件的关联.
结论:
- 甲基胺对儿童的ADHD症状,行为和生活质量有潜在的益处.
- 这些益处的临床意义是不确定的,因为证据质量很低.
- 甲基酸与非严重不良事件的发生率增加有关.
- 需要进一步研究以充分确定安全性,特别是严重不良事件.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
相关概念视频
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
